MIVO® Single-Organ Platform

Integrated microfluidic platform for organ-on-chip and cell culture applications with biocompatible material options. Supports long-term cell maintenance with precise fluidic control for physiological simulation.

Technology platform for developing and testing microphysiological systems that simulate human organ and tissue behavior in vitro. Enables preclinical drug testing, toxicology assessment, and disease modeling with improved physiological relevance compared to conventional cell cultures. Integrates microfluidics, tissue engineering, and analytical capabilities for pharmaceutical and biomedical research applications.

A comprehensive organoid culture and development platform designed for creating three-dimensional tissue models from patient or donor cells. The system supports the establishment and maintenance of organoid biobanks for research and therapeutic applications.

An integrated organoid-based system for preclinical drug screening and development, enabling pharmaceutical companies to test compound efficacy on relevant tissue models.

Microfluidic-based system enabling isolation, analysis, and characterization of individual cells for research and diagnostic applications. Provides high-resolution cellular analysis and sorting capabilities.

Proprietary microfluidics technology platform designed for point-of-care testing and molecular diagnostics applications. Enables precise fluid handling and sample processing in miniaturized formats for rapid diagnostic analysis.

Integrated system for fabricating lab-on-chip devices with precise fluid handling capabilities. Enables miniaturized diagnostic and analytical testing platforms. Supports development of portable diagnostic solutions.

Accurate International Biotechnology provides a comprehensive organoid full lifecycle technology platform for drug development and research. The platform offers high-efficiency screening, precise prediction, controlled risk management, and cost-saving solutions for pharmaceutical enterprises conducting CRO technical services.

A diagnostic platform utilizing microelectromechanical systems (MEMS) and lab-on-a-chip technology for blood disease diagnosis devices. The platform features optical system components with various wavelength channels, thermal control, fluidic and protocol integration, interface-based diverse testing capabilities, and data connectivity with LIS/BIS systems. It provides 99% accuracy, 2X processing speed, and supports 50+ test items.

A versatile wearable and portable platform technology capable of measuring and monitoring multiple biomarkers including glucose, lactate, hormones, and therapeutic drugs. The system utilises nanolitre droplet technology for continuous autonomous measurement.

Integrated in-vitro diagnostic technology combining reagent systems with analytical capabilities for clinical laboratories. Supports multiple testing methodologies and meets requirements of large-scale laboratory operations.

Microfluidic biochip technology for multiplexed biomarker detection and analysis. Supports simultaneous testing of multiple analytes in diagnostic applications.